Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Frusemide (Furosemide) and Reserpine
Trade Name
Terbolan
Manufacturer
Hoechst marion Roussel
Risk Category
C
  • Studies on animals show adverse effect and toxicity on fetus.
  • No adequate and well controlled studies done on pregnant women.
  • Drugs should be given only if the potential benefit outweighs the potential risk to the fetus.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

Indication
Indication
  • diuretic.
  • Antihypertensive.
  • Fetal Risk
    Fetal Risk
  • No adequate data for reserpine, suggested possible association with microcephaly, hydronephrosis and hydroureter and if used near term it may cause nasal discharge, lethargy and anorexia in the newborns.
  • No well – controlled human data for frusemide (Furosemide), suggested possible association with hypospadias in 1st trimester exposure.
  • No fetal adverse effects if used in the last two trimesters but it can induce diuresis in the newborns.
  • Breast Feeding
    Breast Feeding
  • Both drugs are excreted into milk.
  • Reserpine is safe.
  • No adverse effects have been reported with frusemide (Furosemide).
  • Other Trade Names
     
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        You
    Name
    Email
        Your Friend
    Name
    Email
        Comments
     3   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Result
    Month Day Year